Open Access · CC BY-NC 3.0
Immunometabolic Reprogramming in Rheumatoid Arthritis: Mechanistic Evidence, Candidate Biomarkers, and Translational Challenges
Journal of Inflammation Research · 2026-11 · Volume 19 · 1-14
DOI: 10.2147/jir.s639333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-11. Verfasst von Hui Li und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, H., & Li, N. (2026). Immunometabolic Reprogramming in Rheumatoid Arthritis: Mechanistic Evidence, Candidate Biomarkers, and Translational Challenges. Journal of Inflammation Research, Volume 19, 1-14. https://doi.org/10.2147/jir.s639333
Vancouver
Li H, Li N. Immunometabolic Reprogramming in Rheumatoid Arthritis: Mechanistic Evidence, Candidate Biomarkers, and Translational Challenges. Journal of Inflammation Research. 2026;Volume 19:1-14. doi:10.2147/jir.s639333
BibTeX
@article{Li2026,
author = {Li, Hui and Li, Ning},
title = {Immunometabolic Reprogramming in Rheumatoid Arthritis: Mechanistic Evidence, Candidate Biomarkers, and Translational Challenges},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/jir.s639333}
}
EUVIMED